These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 40400)

  • 1. Properties of erythrocyte catalase from heterozygotes for Japanese type acatalasemia.
    Ogata M; Mizugaki J
    Acta Med Okayama; 1979 Jun; 33(3):205-11. PubMed ID: 40400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotitration of the catalase in the blood of Japanese subjects and mice suffering from acatalasemia and hypocatalasemia.
    Ogata M; Fujii Y
    Physiol Chem Phys Med NMR; 1992; 24(4):261-9. PubMed ID: 1296208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyacrylamide gradient gel electrophoretic studies of residual catalase in acatalasemia.
    Ogata M; Mizugaki J; Izumi M; Taketa K
    Physiol Chem Phys Med NMR; 1983; 15(1):31-5. PubMed ID: 6647570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel human catalase mutation (358 T-->del) causing Japanese-type acatalasemia.
    Hirono A; Sasaya-Hamada F; Kanno H; Fujii H; Yoshida T; Miwa S
    Blood Cells Mol Dis; 1995; 21(3):232-4. PubMed ID: 8673475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of erythrocyte catalase from homozygotes and heterozygotes for Swiss-type acatalasemia.
    Aebi H; Wyss SR; Scherz B; Gross J
    Biochem Genet; 1976 Oct; 14(9-10):791-807. PubMed ID: 64244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properties of catalase subfractions separated by chromatofocusing of acatalasemia hemolysates.
    Ogata M; Mizugaki J
    Acta Med Okayama; 1982 Feb; 36(1):73-6. PubMed ID: 7064736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of enzyme variants, polymorphisms and enzyme hybrids in enzyme deficiency conditions.
    Aebi H; Wyss SR
    Acta Biol Med Ger; 1981; 40(4-5):537-41. PubMed ID: 7315100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further genetic heterogeneity in acatalasemia.
    Góth L
    Electrophoresis; 1997 Oct; 18(11):1942-3. PubMed ID: 9420149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished synthesis of catalase due to the decrease in catalase mRNA in Japanese-type acatalasemia.
    Wen JK; Osumi T; Hashimoto T; Ogata M
    Physiol Chem Phys Med NMR; 1988; 20(3):171-6. PubMed ID: 3244798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new type of inherited catalase deficiencies: its characterization and comparison to the Japanese and Swiss type of acatalasemia.
    Góth L
    Blood Cells Mol Dis; 2001; 27(2):512-7. PubMed ID: 11500062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of erythrocyte catalase in Japanese-type acatalasemia by electrofocusing.
    Ogata M; Mizugaki J
    Biochem Genet; 1982 Apr; 20(3-4):265-9. PubMed ID: 7103929
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies of acatalasemia.
    Feinstein RN
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):55-61. PubMed ID: 4611537
    [No Abstract]   [Full Text] [Related]  

  • 13. Catalatic activity of immature and mature red blood cells in Japanese acatalasemia (difference between Japanese and Swiss acatalasemia).
    Ogata M; Tomokuni K; Takahara S
    Acta Med Okayama (1952); 1969 Oct; 23(6):421-8. PubMed ID: 4244050
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular hybridization in heterozygotes for Swiss-type acatalasemia.
    Aebi H; Wyss SR
    Monogr Hum Genet; 1978; 10():200-4. PubMed ID: 723894
    [No Abstract]   [Full Text] [Related]  

  • 15. Erythrocyte metabolism against oxidation in Japanese acatalasemia.
    Takahara S; Ogata M
    Monogr Hum Genet; 1978; 10():205-11. PubMed ID: 723895
    [No Abstract]   [Full Text] [Related]  

  • 16. Carrier state in human acatalasemia.
    NISHIMURA ET; HAMILTON HB; KOBARA TY; TAKAHARA S; OGURA Y; DOI K
    Science; 1959 Aug; 130(3371):333-4. PubMed ID: 13668563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of residual catalase in the erythrocytes of Japanese-type acatalasemia.
    Ogata M; Mizugaki J
    Hum Genet; 1979 May; 48(3):329-38. PubMed ID: 468233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological properties of erythrocyte catalase in Japanese type acatalasemia.
    Ogata M; Mizugaki J
    Acta Med Okayama; 1982 Apr; 36(2):95-8. PubMed ID: 7136855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methemoglobin formation in the blood of Japanese subjects and mice suffering from acatalasemia in response to methemoglobin inducers.
    Ogata M; Ishii K; Ioku N; Meguro T
    Physiol Chem Phys Med NMR; 1990; 22(3):125-34. PubMed ID: 2093192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammalian acatalasemia: the perspectives of bioinformatics and genetic toxicology.
    Ogata M; Wang DH; Ogino K
    Acta Med Okayama; 2008 Dec; 62(6):345-61. PubMed ID: 19122680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.